Sarcopenia associada ao uso prolongado da ventilação mecânica pós covid-19.
Nenhuma Miniatura disponível
Data
2021-12
Tipo de documento
Artigo Científico
Título da Revista
ISSN da Revista
Título de Volume
Área do conhecimento
Modalidade de acesso
Acesso aberto
Editora
Autores
ARAÚJO, Alline Patrícia Evarista de
GOMES, Ellys Tayane Campos
Orientador
BARRETO, Amanda Spínola
Coorientador
CUNHA, Daniela Gibson
Resumo
A sarcopenia é caracterizada pela perda generalizada e progressiva da força e
massa muscular esquelética, sendo a inatividade e hospitalização prolongada em uso
de ventilação mecânica (VM), fatores predisponentes. O COVID-19 enquadra-se nos
riscos de desenvolvimento de sarcopenia, devido ao tempo de inatividade em casos
de hospitalização. O objetivo deste estudo foi analisar o comprometimento da massa
muscular dos indivíduos que foram submetidos ao uso de VM por tempo prolongado,
decorrente do COVID-19. Trata-se de um estudo observacional, transversal e
quantitativo, realizado com 17 pacientes diagnosticados com COVID-19 em estado
grave que fizeram uso de VM por mais de nove dias. Como instrumentos de coleta
foram utilizados: o questionário SARC-F, o SF -36 e questionário on-line desenvolvido
no Google forms, todos aplicados virtualmente. Com base nos nossos dados não
houve relação estatisticamente significativa entre a sarcopenia e variáveis como
idade, dias de internação, sexo, comorbidades, tipos de VM, sequelas e qualidade de
vida. No entanto, foi possível traçar o perfil sociodemográfico dos pacientes e observar
que os sinais de sarcopenia foram mais prevalentes nos indivíduos com maior tempo
de internação, além de estarem associados à pior qualidade de vida. Portanto, concluise que pacientes após longo período de internação em UTI, diagnosticados com covid19, em uso de VM, tendem a desenvolver sarcopenia, tornando-se vulneráveis a
complicações, como dificuldade de locomoção devido ao severo comprometimento da
funcionalidade física e cognitiva. Entretanto, fica o desafio de aprimorar os estudos
com relação à temática.
Sarcopenia is characterized by a generalized and progressive loss of strength and skeletal muscle mass, being predisposing factors: inactivity and prolonged hospitalization with the use of mechanical ventilation (MV). COVID-19 falls within the group of risk factors for developing sarcopenia due to inertness experienced in cases of hospitalization. The aim of this study was to analyze the impairment of muscle mass in individuals who were subjected to long-term use of MV, resulting from COVID-19. This is an observational, cross-sectional and quantitative study, carried out with 17 patients diagnosed with COVID-19 in serious condition who used MV for more than nine days. The following research instruments were used: the SARC-F questionnaire, the SF-36 and the online questionnaire developed in Google forms, all applied virtually. Based on our data, there was no statistically significant relationship between sarcopenia and variables such as age, days of hospitalization, gender, comorbidities, types of MV, sequelae and quality of life. However, it was possible to trace the sociodemographic profile of the patients and to observe that the signs of sarcopenia were more prevalent in individuals with longer hospital stays, in addition to being associated with lower quality of life. Therefore, it is concluded that patients diagnosed with covid-19, using MV after a long period of stay in the ICU, tend to develop sarcopenia, making them vulnerable to complications such as mobility issues due to severe impairment of physical and cognitive functionalities. Nonetheless, the challenge to improve studies on the subject remains.
Sarcopenia is characterized by a generalized and progressive loss of strength and skeletal muscle mass, being predisposing factors: inactivity and prolonged hospitalization with the use of mechanical ventilation (MV). COVID-19 falls within the group of risk factors for developing sarcopenia due to inertness experienced in cases of hospitalization. The aim of this study was to analyze the impairment of muscle mass in individuals who were subjected to long-term use of MV, resulting from COVID-19. This is an observational, cross-sectional and quantitative study, carried out with 17 patients diagnosed with COVID-19 in serious condition who used MV for more than nine days. The following research instruments were used: the SARC-F questionnaire, the SF-36 and the online questionnaire developed in Google forms, all applied virtually. Based on our data, there was no statistically significant relationship between sarcopenia and variables such as age, days of hospitalization, gender, comorbidities, types of MV, sequelae and quality of life. However, it was possible to trace the sociodemographic profile of the patients and to observe that the signs of sarcopenia were more prevalent in individuals with longer hospital stays, in addition to being associated with lower quality of life. Therefore, it is concluded that patients diagnosed with covid-19, using MV after a long period of stay in the ICU, tend to develop sarcopenia, making them vulnerable to complications such as mobility issues due to severe impairment of physical and cognitive functionalities. Nonetheless, the challenge to improve studies on the subject remains.
Palavras-chave
sarcopenia, ventilação mecânica, força muscular, covid-19, fisioterapia